According to this report, the South Korea myopia and presbyopia treatment market is projected to grow at a CAGR of 7.0% between 2023 and 2028. Aided by the increase in the ageing population and ailments like diabetes, along with increased screen time, the market is expected to grow significantly by 2028.
Myopia, or nearsightedness, and presbyopia, a natural, age-related loss of near vision, are two common refractive disorders of the eye, treated with various methods, such as eyeglasses, contact lenses, and refractive surgeries. While myopia is often seen in children and young adults due to extended screen time, presbyopia is prevalent among individuals over 40 years due to the natural ageing process. Both conditions play a significant role in the health and quality of life of the affected individuals, driving the demand for effective treatments.
The South Korea myopia and presbyopia treatment market growth is mainly driven by the increasing screen time among both children and adults, due to digitisation and lifestyle changes. This has led to a rise in vision disorders, especially myopia. In addition, South Korea's ageing population contributes to the prevalence of presbyopia, creating a substantial need for effective treatment options.
The trend towards a more active lifestyle in older age also increases the demand for presbyopia treatment options that allow patients to enjoy activities without the need for reading glasses or bifocals, thus increasing the South Korea myopia and presbyopia treatment market demand. This, coupled with the increasing disposable income and willingness to spend on healthcare in South Korea, leads to growth in demand for more advanced and effective treatments like refractive surgeries.
Furthermore, technological advancements in the ophthalmic industry contribute significantly to South Korea myopia and presbyopia treatment market expansion. The ongoing development of improved surgical procedures, better vision correction devices, and innovative drug therapies enhance treatment outcomes, providing further momentum to the market.
In the South Korean pharmaceutical industry, research and development efforts are also growing to discover new drug therapies for these conditions. Pharmaceutical companies are focusing on developing innovative eye drops and medications that can halt or reverse the progression of myopia and provide relief from presbyopia symptoms, thereby propelling the South Korea myopia and presbyopia treatment market demand.
The high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in this market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation's future success by acquiring one of these reports today.
The analyst always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
Myopia, or nearsightedness, and presbyopia, a natural, age-related loss of near vision, are two common refractive disorders of the eye, treated with various methods, such as eyeglasses, contact lenses, and refractive surgeries. While myopia is often seen in children and young adults due to extended screen time, presbyopia is prevalent among individuals over 40 years due to the natural ageing process. Both conditions play a significant role in the health and quality of life of the affected individuals, driving the demand for effective treatments.
The South Korea myopia and presbyopia treatment market growth is mainly driven by the increasing screen time among both children and adults, due to digitisation and lifestyle changes. This has led to a rise in vision disorders, especially myopia. In addition, South Korea's ageing population contributes to the prevalence of presbyopia, creating a substantial need for effective treatment options.
The trend towards a more active lifestyle in older age also increases the demand for presbyopia treatment options that allow patients to enjoy activities without the need for reading glasses or bifocals, thus increasing the South Korea myopia and presbyopia treatment market demand. This, coupled with the increasing disposable income and willingness to spend on healthcare in South Korea, leads to growth in demand for more advanced and effective treatments like refractive surgeries.
Furthermore, technological advancements in the ophthalmic industry contribute significantly to South Korea myopia and presbyopia treatment market expansion. The ongoing development of improved surgical procedures, better vision correction devices, and innovative drug therapies enhance treatment outcomes, providing further momentum to the market.
In the South Korean pharmaceutical industry, research and development efforts are also growing to discover new drug therapies for these conditions. Pharmaceutical companies are focusing on developing innovative eye drops and medications that can halt or reverse the progression of myopia and provide relief from presbyopia symptoms, thereby propelling the South Korea myopia and presbyopia treatment market demand.
Market Segmentation
The market can be divided based on disease type and treatment type.Market Breakup by Disease Type
- Myopia
- Presbyopia
Market Breakup by Treatment Type
- Prescription Lenses
- Contact Lenses
- Intraocular Lenses
- Refractive Surgery
- Drugs
Competitive Landscape
This report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the South Korea myopia and presbyopia treatment companies. Some of the major key players explored in this report are as follows:- Johnson & Johnson Vision
- T Korea Solution Co., Ltd.
- Alcon Inc.
- AbbVie
- HOYA Corporation
- Others
About the Analyst
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.The high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in this market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation's future success by acquiring one of these reports today.
The analyst always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
Table of Contents
1 Preface2 Report Coverage - Key Segmentation and Scope4 Key Assumptions6 Market Snapshot7 Opportunities and Challenges in the Market13 Key Trends and Developments in the Market
3 Report Description
5 Executive Summary
8 South Korea Myopia and Presbyopia Treatment Market Analysis
9 South Korea Myopia and Presbyopia Treatment Market by Disease Type
10 South Korea Myopia and Presbyopia Treatment Market by Treatment Type
11 Market Dynamics
12 Competitive Landscape
List of Figures and Tables
Companies Mentioned
- Johnson & Johnson Vision
- T Korea Solution Co. Ltd.
- Alcon Inc.
- AbbVie
- HOYA Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 172 |
| Published | October 2023 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value ( USD | $ 49.72 Million |
| Forecasted Market Value ( USD | $ 69.73 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | South Korea |
| No. of Companies Mentioned | 5 |
